Clin2
NCT07708688Possibly a fitNot yet recruiting

Looking for VEXAS syndrome in internal medicine

Vexas Syndrome

Part of Blood & lymphatic, Genetic & congenital clinical trials.

This trial looks for people age 50+ with unexplained inflammation or blood problems like anemia or low platelets. It aims to better identify a rare condition called VEXAS syndrome, which causes these symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
50 years and older
Study type
Observational

Who can take part

  • You must be 50 years or older.
  • You must be admitted to an Internal Medicine department in the FADOI network (Friuli Venezia Giulia, Italy).
  • You must have signs of unexplained inflammation or blood problems, such as fever, high CRP/ESR, anemia, or low platelets.
  • Your symptoms should not be fully explained by an infection or cancer.
  • You need to have medical records available for review, and give consent if required.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06377462Recruiting
VEXAS syndrome registry with blood sample collection

This study creates a national registry for people with VEXAS syndrome to track the disease and collect blood samples for research. Joining helps doctors learn more about VEXAS so they can better diagnose and treat it in the future.

Aachen
NCT07748624Not yet recruiting· Phase 2
Testing a new drug for people with VEXAS

This study tests an investigational drug called arumakimig (MAS825) in people with VEXAS, a rare genetic condition that causes inflammation. The trial checks if the drug helps control symptoms and improve quality of life.

NCT07569081Not yet recruiting· Phase 2/Phase 3
Testing momelotinib for VEXAS syndrome

This trial tests whether a new drug called momelotinib can help treat VEXAS syndrome, a rare genetic inflammatory condition. The study will see if it can reduce inflammation and allow patients to use less steroid medication.

NCT06538181Recruiting· Phase 1
Testing pacritinib for VEXAS syndrome

This trial tests a new drug called pacritinib for people with VEXAS syndrome, a rare autoinflammatory condition. The goal is to see if pacritinib can help control symptoms like rashes, joint pain, and low blood counts.

St Louis, Missouri
NCT06004349Recruiting
Genetic study of autoinflammatory diseases

This study looks for genes linked to autoinflammatory diseases like VEXAS syndrome. You or your family member can join by mailing in a blood or saliva sample to help researchers better understand these conditions.

New York, New York
NCT06657846Recruiting
Quality of life and costs for people with VEXAS

This study looks at how VEXAS syndrome affects your daily life and finances. It aims to understand the challenges you face so doctors can better support you.

Ancona

Hear when a new VEXAS Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.